Gujarat Themis Biosyn Ltd.
NSE: GUJTHEM | BSE: 506879
₹357.10
₹1.50
(0.42%)
As on 21-May-2026IST
Market cap
₹3,891 Cr
Revenue (TTM)
₹159 Cr
P/E Ratio
81.4
P/B Ratio
14.1
Div. Yield
0.2 %
Quality Score
9/10
Growth Score
6/10
Valuation Score
2/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹48 Cr
-
ROE
21.7 %
-
ROCE
27.5 %
-
Industry P/E
37.35
-
EV/EBITDA
52.6
-
Debt to Equity
0.1
-
Book Value
₹25.4
-
EPS
₹4.4
-
Face value
1
-
Shares outstanding
108,965,265
10 Years Aggregate
CFO
₹259.18 Cr
EBITDA
₹377.10 Cr
Net Profit
₹282.67 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Gujarat Themis
| -19.1 | 7.2 | 6.4 | 9.6 | -- | -- | -- |
|
BSE Healthcare
| 10.2 | 10.3 | 11.1 | 13.4 | 28.1 | 14.5 | 12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Gujarat Themis
|
357.1 | 3,891.2 | 159.3 | 47.8 | 39.0 | 18.6 | 81.4 | 14.1 |
| 1,056.5 | 12,957.0 | 2,551.8 | 564.5 | 28.3 | 18.4 | 23 | 3.9 | |
| 440.0 | 7,618.6 | 1,053.1 | 293.6 | 32.3 | 24.6 | 26 | 5.9 | |
| 1,123.3 | 11,759.4 | 1,158.7 | 309.6 | 31.9 | 17.3 | 37.6 | 6.2 | |
| 1,751.5 | 33,199.0 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.9 | 6.7 | |
| 16,690.0 | 21,397.2 | 2,023.0 | 364.0 | 23.9 | 20.8 | 58.8 | 11.4 | |
| 707.6 | 3,586.9 | 811.2 | 17.4 | 0.8 | 2.1 | 190.1 | 2.8 | |
| 2,274.2 | 3,757.0 | 707.5 | 115.2 | 17.8 | 19.4 | 32.6 | -- | |
| 1,109.4 | 5,101.4 | 649.5 | 121.6 | 23.7 | 13.2 | 44.2 | 5.5 | |
| 269.5 | 7,078.3 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.0 |
Shareholding Pattern
View DetailsNews & Analysis
All News
About Gujarat Themis
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of... tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India. Read more
-
Incorporated
1981
-
Chairman
Dinesh S Patel
-
Managing Director
Sachin D Patel
-
Headquarters
Valsad Dist, Gujarat
-
Website
Looking for more details about Gujarat Themis Biosyn Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Gujarat Themis
What is the current share price of Gujarat Themis Biosyn Ltd Today?
The share price of Gujarat Themis Biosyn Ltd is ₹357.10 (NSE) and ₹357.10 (BSE) as of 21-May-2026 IST. Gujarat Themis Biosyn Ltd has given a return of 9.64% in the last 1 years.
What is the current PB & PE ratio of Gujarat Themis Biosyn Ltd?
The P/E ratio of Gujarat Themis Biosyn Ltd is 81.43 times as on 21-May-2026, a 118 premium to its peers’ median range of 37.35 times.
The P/B ratio of Gujarat Themis Biosyn Ltd is 14.05 times as on 21-May-2026, a 495 premium to its peers’ median range of 2.36 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
62.89
|
12.35
|
|
2024
|
32.42
|
14.29
|
|
2023
|
2.29
|
6.69
|
|
2022
|
1.81
|
5.73
|
|
2021
|
1.31
|
4.23
|
What is the 52 Week High and Low of Gujarat Themis Biosyn Ltd?
The 52-week high and low of Gujarat Themis Biosyn Ltd are Rs 479.00 and Rs 225.05 as of 21-May-2026.
What is the market cap of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd has a market capitalisation of ₹ 3,891 Cr as on 21-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Gujarat Themis Biosyn Ltd?
Before investing in Gujarat Themis Biosyn Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.